Rupangi C. Vasavada

4.6k total citations
53 papers, 3.6k citations indexed

About

Rupangi C. Vasavada is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Rupangi C. Vasavada has authored 53 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Surgery, 32 papers in Molecular Biology and 26 papers in Genetics. Recurrent topics in Rupangi C. Vasavada's work include Pancreatic function and diabetes (41 papers), Diabetes and associated disorders (20 papers) and Metabolism, Diabetes, and Cancer (20 papers). Rupangi C. Vasavada is often cited by papers focused on Pancreatic function and diabetes (41 papers), Diabetes and associated disorders (20 papers) and Metabolism, Diabetes, and Cancer (20 papers). Rupangi C. Vasavada collaborates with scholars based in United States, Austria and Canada. Rupangi C. Vasavada's co-authors include Andrew F. Stewart, Adolfo Garcı́a-Ocaña, Karen K. Takane, William M. Philbrick, Nathalie Fiaschi‐Taesch, Pamela Dann, John J. Wysolmerski, Irene Cózar‐Castellano, Kai Hao Yang and A E Broadus and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Physiological Reviews.

In The Last Decade

Rupangi C. Vasavada

50 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rupangi C. Vasavada United States 31 2.1k 1.8k 1.3k 981 756 53 3.6k
Karen K. Takane United States 33 1.8k 0.9× 1.3k 0.7× 1.2k 0.9× 872 0.9× 291 0.4× 40 2.6k
Fraser M. Rogerson Australia 28 458 0.2× 898 0.5× 386 0.3× 1.2k 1.2× 219 0.3× 39 2.8k
Peter A. Cattini Canada 32 446 0.2× 2.0k 1.1× 810 0.6× 841 0.9× 139 0.2× 130 3.3k
Yasuhiro Kosaka United States 18 741 0.3× 726 0.4× 372 0.3× 303 0.3× 203 0.3× 50 1.8k
Harald Jüppner United States 28 1.0k 0.5× 3.5k 1.9× 2.4k 1.9× 558 0.6× 1.6k 2.2× 65 6.4k
Billie M. Moats‐Staats United States 24 485 0.2× 796 0.4× 342 0.3× 988 1.0× 169 0.2× 46 2.1k
Bonald C. Figueiredo Brazil 28 1.3k 0.6× 959 0.5× 417 0.3× 595 0.6× 337 0.4× 82 2.7k
R. Clay Bunn United States 28 312 0.1× 1.2k 0.7× 288 0.2× 541 0.6× 434 0.6× 46 2.6k
Michelina Plateroti France 28 337 0.2× 1.1k 0.6× 761 0.6× 1.1k 1.1× 407 0.5× 62 2.5k
Paul D. Upton United Kingdom 38 710 0.3× 1.8k 1.0× 209 0.2× 144 0.1× 423 0.6× 76 5.2k

Countries citing papers authored by Rupangi C. Vasavada

Since Specialization
Citations

This map shows the geographic impact of Rupangi C. Vasavada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupangi C. Vasavada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupangi C. Vasavada more than expected).

Fields of papers citing papers by Rupangi C. Vasavada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupangi C. Vasavada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupangi C. Vasavada. The network helps show where Rupangi C. Vasavada may publish in the future.

Co-authorship network of co-authors of Rupangi C. Vasavada

This figure shows the co-authorship network connecting the top 25 collaborators of Rupangi C. Vasavada. A scholar is included among the top collaborators of Rupangi C. Vasavada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupangi C. Vasavada. Rupangi C. Vasavada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Filipowska, Joanna, Peng Wang, Geming Lu, et al.. (2025). LGR4 is essential for maintaining β-cell homeostasis through suppression of RANK. Molecular Metabolism. 92. 102097–102097. 2 indexed citations
2.
Filipowska, Joanna, Jeong‐su Do, Selassie Ogyaadu, et al.. (2023). RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes. Science Advances. 9(44). eadf5238–eadf5238. 11 indexed citations
3.
Sacaan, Aida, Stéphane Thibault, Tim Nichols, et al.. (2017). CDK4/6 Inhibition on Glucose and Pancreatic Beta Cell Homeostasis in Young and Aged Rats. Molecular Cancer Research. 15(11). 1531–1541. 17 indexed citations
4.
5.
Álvarez-Pérez, Juan Carlos, Carolina Rosselot, Gabriella Casinelli, et al.. (2016). PKCζ Is Essential for Pancreatic β-Cell Replication During Insulin Resistance by Regulating mTOR and Cyclin-D2. Diabetes. 65(5). 1283–1296. 38 indexed citations
6.
Fenutría, Rafael, Ilana Pollack, Michael Orthofer, et al.. (2015). Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway. Cell Metabolism. 22(1). 77–85. 126 indexed citations
7.
Wang, Peng, Nathalie Fiaschi‐Taesch, Rupangi C. Vasavada, et al.. (2015). Diabetes mellitus—advances and challenges in human β-cell proliferation. Nature Reviews Endocrinology. 11(4). 201–212. 170 indexed citations
8.
9.
Dubé, John J., Shelley Valle, Taylor C. Rosa, et al.. (2010). Novel Proapoptotic Effect of Hepatocyte Growth Factor: Synergy with Palmitate to Cause Pancreatic β-Cell Apoptosis. Endocrinology. 151(4). 1487–1498. 14 indexed citations
10.
Zhang, Hongjie, Jia Zhang, Laura Crawford, et al.. (2009). Gestational Diabetes Mellitus Resulting From Impaired β-Cell Compensation in the Absence of FoxM1, a Novel Downstream Effector of Placental Lactogen. Diabetes. 59(1). 143–152. 144 indexed citations
11.
Fujinaka, Yuichi, Karen K. Takane, Hiroko Yamashita, & Rupangi C. Vasavada. (2007). Lactogens Promote Beta Cell Survival through JAK2/STAT5 Activation and Bcl-XL Upregulation. Journal of Biological Chemistry. 282(42). 30707–30717. 70 indexed citations
12.
Vasavada, Rupangi C., et al.. (2005). Growth factors and beta cell replication. The International Journal of Biochemistry & Cell Biology. 38(5-6). 931–950. 111 indexed citations
13.
Cózar‐Castellano, Irene, et al.. (2004). Hepatocyte growth factor gene therapy for islet transplantation. Expert Opinion on Biological Therapy. 4(4). 507–518. 20 indexed citations
14.
Garcı́a-Ocaña, Adolfo, et al.. (2002). Adenovirus-mediated Hepatocyte Growth Factor Expression in Mouse Islets Improves Pancreatic Islet Transplant Performance and Reduces Beta Cell Death. Journal of Biological Chemistry. 278(1). 343–351. 104 indexed citations
15.
Cebrián, Ana, et al.. (2002). Overexpression of Parathyroid Hormone-Related Protein Inhibits Pancreatic β-Cell Death In Vivo and In Vitro. Diabetes. 51(10). 3003–3013. 51 indexed citations
16.
Garcı́a-Ocaña, Adolfo, Rupangi C. Vasavada, Ana Cebrián, et al.. (2001). Transgenic Overexpression of Hepatocyte Growth Factor in the β-Cell Markedly Improves Islet Function and Islet Transplant Outcomes in Mice. Diabetes. 50(12). 2752–2762. 135 indexed citations
17.
Garcı́a-Ocaña, Adolfo, Rupangi C. Vasavada, Karen K. Takane, et al.. (2001). Using β-Cell Growth Factors to Enhance Human Pancreatic Islet Transplantation*. The Journal of Clinical Endocrinology & Metabolism. 86(3). 984–988. 53 indexed citations
18.
Vasavada, Rupangi C., Adolfo Garcı́a-Ocaña, Walter S. Zawalich, et al.. (2000). Targeted Expression of Placental Lactogen in the Beta Cells of Transgenic Mice Results in Beta Cell Proliferation, Islet Mass Augmentation, and Hypoglycemia. Journal of Biological Chemistry. 275(20). 15399–15406. 170 indexed citations
19.
Vasavada, Rupangi C., et al.. (1998). Parathyroid hormone-related protein in the pancreatic islet and the cardiovascular system.. PubMed. 53. 305–38; discussion 338. 19 indexed citations
20.
Vasavada, Rupangi C., Christi M. Cavaliere, A. Joseph D’Ercole, et al.. (1996). Overexpression of Parathyroid Hormone-related Protein in the Pancreatic Islets of Transgenic Mice Causes Islet Hyperplasia, Hyperinsulinemia, and Hypoglycemia. Journal of Biological Chemistry. 271(2). 1200–1208. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen K. Takane Breakdown of academic impact, for papers by Fraser M. Rogerson Breakdown of academic impact, for papers by Peter A. Cattini Breakdown of academic impact, for papers by Yasuhiro Kosaka Breakdown of academic impact, for papers by Harald Jüppner Breakdown of academic impact, for papers by Billie M. Moats‐Staats Breakdown of academic impact, for papers by Bonald C. Figueiredo Breakdown of academic impact, for papers by R. Clay Bunn Breakdown of academic impact, for papers by Michelina Plateroti Breakdown of academic impact, for papers by Paul D. Upton
Rankless by CCL
2026